News

ZoBio of Leiden has been selected by pharmaceutical company UCB to provide ligand discovery services for fragment-based drug discovery.

Kinaxo Biotechnologies GmbH, of Martinsried, was awarded a Euro 1 million grant from the German Ministry for Education and Research to develop a technology platform for quantifying interactions between small molecule drugs and proteins in mammalian tissues and cell lines.